What's hot & what's not?

Federal Budget Data

You are currently displaying the option highlighted by the icon below. To display options mouse over the icon then click to select.


Each result begins with a chart showing totals for each year of budget data. Click on the point to drill down.
Health Portfolio
AgencyNational Blood Authority
ProgramNational Blood Agreement Management
ComponentNational Blood Authority Account
Outcome
Outcome 1: Access to a secure supply of safe and affordable blood products, including through national supply arrangements and coordination of best practice standards within agreed funding policies under the national blood arrangements.

$1,171,220,000
1,171.22M
$1,253,439,000
1,253.44M
$1,333,794,000
1,333.79M
$1,445,933,000
1,445.93M
$1,578,877,000
1,578.88M
2017 Year to date
2018 May budget
2019 Estimate
2020 Projection
2021 Projection


Health Portfolio
AgencyNational Blood Authority
ProgramNational Blood Agreement Management
ComponentNational Blood Authority Account
Outcome
Outcome 1: Access to a secure supply of safe and affordable blood products, including through national supply arrangements and coordination of best practice standards within agreed funding policies under the national blood arrangements.

$9,457,000
9.46M
$9,631,000
9.63M
$9,638,000
9.64M
$9,409,000
9.41M
$9,460,000
9.46M
2017 Year to date
2018 May budget
2019 Estimate
2020 Projection
2021 Projection


Health Portfolio
AgencyNational Blood Authority
ProgramNational Blood Agreement Management
ComponentDepartmental appropriation
Outcome
Outcome 1: Access to a secure supply of safe and affordable blood products, including through national supply arrangements and coordination of best practice standards within agreed funding policies under the national blood arrangements.

$5,590,000
5.59M
$5,682,000
5.68M
$5,686,000
5.69M
$5,531,000
5.53M
$5,562,000
5.56M
2017 Year to date
2018 May budget
2019 Estimate
2020 Projection
2021 Projection


Health Portfolio
AgencyNational Blood Authority
ProgramNational Blood Agreement Management
ComponentOrdinary annual services
Outcome
Outcome 1: Access to a secure supply of safe and affordable blood products, including through national supply arrangements and coordination of best practice standards within agreed funding policies under the national blood arrangements.

$3,860,000
3.86M
$3,404,000
3.40M
$0,000
0.00M
$0,000
0.00M
$0,000
0.00M
2017 Year to date
2018 May budget
2019 Estimate
2020 Projection
2021 Projection


Health Portfolio
AgencyNational Blood Authority
ProgramNational Blood Agreement Management
ComponentExpenses not requiring appropriation in the budget year
Outcome
Outcome 1: Access to a secure supply of safe and affordable blood products, including through national supply arrangements and coordination of best practice standards within agreed funding policies under the national blood arrangements.

$418,000
0.42M
$392,000
0.39M
$592,000
0.59M
$559,000
0.56M
$559,000
0.56M
2017 Year to date
2018 May budget
2019 Estimate
2020 Projection
2021 Projection


Health Portfolio
AgencyNational Blood Authority
ProgramNational Blood Agreement Management
Componentto National Managed Fund Blood and Blood Products Special Account
Outcome
Outcome 1: Access to a secure supply of safe and affordable blood products, including through national supply arrangements and coordination of best practice standards within agreed funding policies under the national blood arrangements.

$0,000
0.00M
$0,000
0.00M
$0,000
0.00M
$0,000
0.00M
$0,000
0.00M
2017 Year to date
2018 May budget
2019 Estimate
2020 Projection
2021 Projection


Health Portfolio
AgencyNational Blood Authority
ProgramNational Blood Agreement Management
ComponentNational Managed Fund Blood and Blood Products Special Account
Outcome
Outcome 1: Access to a secure supply of safe and affordable blood products, including through national supply arrangements and coordination of best practice standards within agreed funding policies under the national blood arrangements.

$0,000
0.00M
$0,000
0.00M
$0,000
0.00M
$0,000
0.00M
$0,000
0.00M
2017 Year to date
2018 May budget
2019 Estimate
2020 Projection
2021 Projection


Health Portfolio
AgencyNational Blood Authority
ProgramNational Blood Agreement Management
ComponentOperating deficit surplus
Outcome
Outcome 1: Access to a secure supply of safe and affordable blood products, including through national supply arrangements and coordination of best practice standards within agreed funding policies under the national blood arrangements.

$1,784,000
1.78M
$0,000
0.00M
$0,000
0.00M
$0,000
0.00M
$0,000
0.00M
2017 Year to date
2018 May budget
2019 Estimate
2020 Projection
2021 Projection


Health Portfolio
AgencyNational Blood Authority
ProgramNational Blood Agreement Management
Componentto National Blood Authority Account
Outcome
Outcome 1: Access to a secure supply of safe and affordable blood products, including through national supply arrangements and coordination of best practice standards within agreed funding policies under the national blood arrangements.

$-3,860,000
-3.86M
$-3,404,000
-3.40M
$0,000
0.00M
$0,000
0.00M
$0,000
0.00M
2017 Year to date
2018 May budget
2019 Estimate
2020 Projection
2021 Projection


Health Portfolio
AgencyNational Blood Authority
ProgramNational Blood Agreement Management
Componentto National Blood Authority Account
Outcome
Outcome 1: Access to a secure supply of safe and affordable blood products, including through national supply arrangements and coordination of best practice standards within agreed funding policies under the national blood arrangements.

$-5,590,000
-5.59M
$-5,682,000
-5.68M
$-5,686,000
-5.69M
$-5,531,000
-5.53M
$-5,562,000
-5.56M
2017 Year to date
2018 May budget
2019 Estimate
2020 Projection
2021 Projection


×